Company intelligence / Profile preview

Provital, S.A.

Barberà del Vallès, Barcelona, Spainweareprovital.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Provital develops and markets a wide range of sustainable and innovative active ingredients for the global cosmetics industry. Their portfolio includes plant stem cell extracts and endophyte-derived actives using proprietary biotech platforms like Triplobiome™. Recent launches include Shiloxome™, an endophyte-based anti-aging ingredient with demonstrated efficacy in skin lipidomics studies. The company emphasizes sustainability and scientific innovation but does not conduct pharmaceutical clinical trials.

Therapeutic areas: OtherPsychiatryDermatology
Modalities: Plant stem cell-based ingredientsEndophyte-based biotechnology productsFermentation-derived actives
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Provital, S.A..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Provital, S.A..

Explore the full profile